GRAL INVESTOR ALERT: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead the Grail Class Action Lawsuit – RGRD Law

A class action lawsuit has been filed against GRAIL, Inc. for allegedly making false statements about its NHS-Galleri cancer screening trial. The company failed to achieve the primary endpoint of demonstrating a statistically significant reduction in Stage III-IV cancers, leading to a stock price decline of over 50% on February 19, 2026. Investors who purchased GRAIL stock between May 13, 2025 and February 19, 2026 are eligible to participate.